Caged Ligands for Spatiotemporal Gene Expression Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current inducible gene expression systems lack fine spatial and temporal control, making it difficult to study the role of specific genes in mammary gland tumorigenesis and other biological processes, as they often result in mosaic induction, toxicity, and poor expression profiles.
Innovation Solution
The use of caged ligands that react with receptors not naturally present in mammals, allowing for precise spatial and temporal control of gene expression through light activation, using compounds with a molecular cage that prevents ligand-receptor interaction until exposed to light.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional inducible gene expression systems are used, then gene expression can be induced, but spatial and temporal control is poor resulting in mosaic induction
Solution Approach 1:
The patent introduces a molecular cage as an intermediary that temporarily blocks the ligand-receptor interaction. The caged ligand serves as a prodrug form that can be administered systemically without immediate effect, then activated by light exposure at specific locations and times to produce the active ligand that binds to the receptor and induces gene expression. This mediator enables precise spatiotemporal control while ensuring reliable uniform induction in the targeted area.
Solution Approach 2:
The caged ligand is administered to the organism in advance before the desired gene expression induction. The ligand is pre-positioned in the target tissue in an inactive form, then activated by light exposure at the precise moment and location when gene expression is desired. This preliminary action allows the system to be ready for induction without premature activation, improving both spatial control and induction uniformity.
2Reliability
If traditional inducible gene expression systems are used, then gene expression can be induced, but toxicity occurs
Solution Approach 1:
The molecular cage acts as a protective intermediary that masks the toxic or biologically active ligand during administration and distribution. The caged form is chemically modified to reduce or eliminate toxicity while maintaining the ability to generate the active ligand upon light exposure. This allows the ligand to be administered systemically at higher doses without causing toxicity, then locally activated where needed.
Solution Approach 2:
The patent separates the toxic properties from the active gene-inducing properties by chemically modifying the ligand with a molecular cage. The caged ligand lacks the toxic effects of the native ligand but retains the capacity to generate the active form through photolysis. This extraction of toxicity allows safe systemic administration followed by localized activation.
3Reliability
If traditional inducible gene expression systems are used, then gene expression can be induced, but induction specificity is low
Solution Approach 1:
The molecular cage serves as a light-activated mediator that converts a systemically administered prodrug into the active ligand only at sites of light exposure. This enables precise spatial control of gene expression induction, affecting only the cells and tissues illuminated by the activating light source. The cage-ligand-receptor system provides high induction specificity by restricting activation to the targeted region.
Solution Approach 2:
The patent replaces the traditional mechanical or chemical delivery control system with a photonic activation system. Instead of relying on complex delivery mechanisms to achieve spatial control, the system uses light exposure to activate the caged ligand at precise locations. This substitution of activation mechanism enables superior spatial and temporal control of gene expression induction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise regulation of gene expression in mammalian cells and whole animals, avoiding unwanted physiological effects and providing high induction specificity, allowing for the study of gene function in specific tissues and during specific times.
Implementation Method 1
a molecular cage covalently bound to the ligand that prevents reaction of the ligand with the first receptor, where the ligand is released from the cage upon exposure of the compound to light
Data Source
AI summary
Provided are caged compounds comprising a ligand that specifically reacts with a receptor not naturally present in mammals. The cage is released from the ligand upon illumination of the compound with light. Also provided are cells transfected with a gene of interest and a gene encoding a receptor, the gene of interest operably linked to a genetic element capable of being induced by the receptor when bound to a ligand, and the receptor not naturally present in the species of the cell. The cells also comprise a caged ligand of the receptor. Additionally provided are methods of inducing a gene of interest in the above cells. Also provided are methods of repressing a gene of interest in a cell using caged ligands of receptors. Methods are additionally provided for inducing elimination of a target sequence in a cell of a species, using a caged ligand and a recombinase.